Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis
RS is a feasible alternative to SCC for ECT, with acceptable recovery and fewer side effects without affecting the seizure duration. However, larger high-quality randomized controlled trials are necessary to statistically substantiate these findings and assess the long-term outcomes.
Authors
- Deb Sanjay Nag (ORCID: https://orcid.org/0000-0003-2200-9324)
- Rishi Anand (ORCID: https://orcid.org/0000-0001-9046-6178)
- Roshan Lal Gope
- Roushan Patel
- Murari Kumar Bharadwaj
- Bappa Ditya Pal
- Mohd Amir Ansari
- Srirala Shivani
- Manoj Kumar Sahoo
- Pratul Bhushan
Institutions
- Tata Main Hospital (IN)
Publication Details
- Journal
- World Journal of Psychiatry
- Published
- 2026-01-29
- DOI
- https://doi.org/10.5498/wjp.v16.i2.112462
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00